Back

Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Renal failure and heart disease: epidemiology and mechanisms Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

5 More presentations in this session

Presentation thumbnail
Impact of kidney function, ticagrelor and genetic polymorphism on high platelet reactivity
Professor W. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Geographic differences in serious bleeding event rates and clinical profiles among patients with ESKD who receive peritoneal or hemodialysis, 2009-2022
Doctor M. Bonaca (Aurora, US)
Abstract Slides Video
Presentation thumbnail
The impacts of the initiation of hemodialysis for patients with newly diagnosed end-stage renal disease and normal left ventricular systolic function
Doctor Y. Fu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
The impact of pulmonary hypertension on early postoperative period after lung transplantation with particular emphasis on kidney function
Ms M. Wajda-Pokrontka (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Worsening renal function in patients admitted with congestive heart failure: prevalence, risk profile, and hospital readmissions
Ms A. Alshammari (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Renal failure and heart disease: epidemiology and mechanisms

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources